RI revealed a soft tissue mass in the sella causing its expansion. The mass was hypoint t tense on T1W images (Figure1a) showing peripheral enhancement on post gadolinium image (Figure 1b). A plain radiograph of the hands shows osteopenia with subperiosteal erosion in the phalant t ges (Figure 2) . A diagnosis of pituitary macroadenoma was suggested based on the MR appearance. She was put on bromocriptine therapy following which her pet t riods became regular. In view of subperiosteal erosion seen on the plain radiograph, a suspicion of hyperparat t thyroidism was made as subperiosteal erosion of the bone, particularly along the radial aspect of the middle phalanx of middle and index finger, which is virtually pathognomonic for hyperparathyroidism although ost t teopenia can be found in other conditions, viz. osteot t malacia, multiple myeloma. Contrast enhanced CT scan of neck was performed, which revealed enlarged right inferior parathyroid gland. MRI of the abdomen was also performed which revealed a small well defined Diagnosis: Multiple endocrine neoplasia type 1 (MEN 1), also known as Wermer's syndrome Chandan Jyoti Das,* Jyotindu Debnath,* NG Javan, † Manash Pratim Baruah ‡ space occupying lesion in the proximal body of pant t creas, which was uniformly hypointense on T1W imt t age and hyperintense on T2W image (Figure 3a, 3b) . Bilateral adrenal hyperplasia was also noted. Based on the clinical profile, laboratory findings and imaging apt t pearance, a diagnosis of MEN 1 syndrome was suggestt t ed. She underwent transtsphenoidal decompression of the mass and histopathology confirmed the diagnosis of pituitary adenoma. The patient also underwent total parathyroidectomy, enucleation of the pancreatic tut t mor. Histopathology of the resected specimens showed parathyroid hyperplasia and neuroendocrine tumor of the pancreas. She is on clinical follow up and is doing well.
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Discussion
Multiple endocrine neoplasia type 1 (MEN 1) also known as Wermer' s syndrome, is an autosomal domit t nant genetic syndrome characterized by a predisposition of simultaneous or successive development of neoplasia what's your diagnosis?
MulTiplE EndOcRinE nEOplASiA and or hyperplasia of several endocrine glands. 1 It is caused by a germ line mutation in the MEN 1 gene lot t cus coding for a tumor suppressor protein, called menin. 2 Jacob Erdheim in 1903 first described this condition in a patient with tumors involving two endocrine organs, the pituitary gland and the parathyroid glands and almost six decades later Steiner et al introduced the term "Multiple Endocrine Neoplasia" to describe a combination of tut t mors of three different types of endocrine glands viz. familial parathyroid, pituitary and pancreatic islet cell tumors (MEN type 1), familial pheochromocytoma, medullary thyroid carcinoma and hyperparathyroidism (MEN type 2) and non familial parathyroid tumors and papillary thyroid carcinomas (MEN type 3) . 3 Classical MEN 1 includes primary hyperparathyroidism (HPT), enteropancreatic neuroendocrine tumors (EPNET) and pituitary adenomas. 4 Primary hyperparathyroidism is the most common manifestation of MEN 1 syndrome and most of the aft t fected individuals develop hypercalcemia by age 40. Parathyroid hyperplasia is the most common cause of hyperparathyroidism in MEN 1, although single and multiple adenomas have been described. 5 Manifestations of hyperparathyroidism in MEN 1 includes nephrolithit t asis, pathological fractures, gastrointestinal and muscut t loskeletal complaints. Enteropancreatic neuroendocrine tumors (EPNET) are the second most common manit t festation of MEN 1.
1 Most frequent tumors are gastrinot t mas and insulinomas. 1 Early identification of EPNET is of critical importance as these tumors represent the most frequent cause of death with this syndrome. 2 Pituitary tumors occur in more than half of patients with MEN 1 and tend to be multicentric, making them difficult to resect. Prolactinomas are the most common and are dit t agnosed by finding serum prolactin levels >200 µg/L and can be picked up on dynamic CEMRI. 5 Clinical symptom depends on the size of the adenoma and the intensity of hormone secretion. In addition, MEN 1 cart t riers can have various other endocrine or non endocrine lesions like adrenal hyperplasia, thymoma, thymic and foregut carcinoids. 3 The diagnosis of MEN 1 syndrome is established by family screening, clinical data, and appropriate hormonal assay and stimulation tests. Family history of similar dist t ease is very important as firsttdegree relatives of MEN 1 patient have about 50% risk of development of the dist t ease. 6 Imaging studies play a crucial role in identification of the target organs of lesions suspected on the basis of clinical and laboratory findings, staging of malignant let t sions and search for an occult cotexisting lesion to ent t able correct medical and or surgical treatment planning. For parathyroid lesion, high resolution ultrasonography (US) of neck preferably with a linear probe is the initial imaging modality of choice. If neck US is negative, CT, MRI or nuclear scintigraphy is indicated for demonstrat t tion of ectopic location of parathyroid in the anterior met t diastinum. 1 Currently MRI is the technique of choice for evaluation of the pituitary tumors in MEN 1 patients. 1 Abdominal USG has a sensitivity of about 60% for int t sulinoma, and 20t30% for gastrinoma. Endoscopic ultrat t sonography (EUS) has improved the rate of detection of tumors in the pancreas and duodenal wall. Intraoperative USG combined with surgical palpation is another relit t able method for detection of EPNET.
1 CT has overall sensitivity of 50% for the detection of pancreatic endot t crine tumors. In addition to locoregional staging, USG and CT are particularly useful for detection of liver met t tastases, which is crucial before any definite therapeut t tic planning. 1 Somatostatin receptor scintigraphy and selective intratarterial stimulation testing with secretin have been found to have greatest sensitivity in localizing gastrinoma. 1 MRI has an important role in identificat t tion of EPNET. The use of fast spin echo (FSE) and fat saturation techniques are particularly useful in imaging pancreatic lesion especially islet cell tumor. 7 Genetic screening in first degree relatives of MEN1 patients may be advisable during early adolescence to ast t sess risk of developing MEN1 in future. In symptomatic individuals of MEN1, annual clinical and biochemical (calcium, PTH, gastrin, prolactin) followtup as well as routine pancreatic and pituitary imaging may be complet t mented on individual merit basis.
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